EISAI Trial Site 5

Tübingen

0 studies enrolling now · 1 studies all time

What they study most

Endometrial Neoplasms

Studies at this site

• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed